The ColdChainer Briefing
Manifest is an annual supply chain and logistics technology conference and expo drawing 8,500+ attendees, 400+ speakers and a large startup/investor contingent across every transport mode. Within it sits the Cold Chain Experience, a dedicated two-day pavilion and session track spanning food and grocery logistics, life sciences and pharmaceutical supply chains, and temperature-controlled transportation. The 2027 edition runs 8-10 February at The Venetian in Las Vegas.
The cold chain program is where large shippers, cold-storage operators and temperature-controlled carriers meet the startup and venture-capital side backing next-generation monitoring, last-mile and cold-storage technology. Sessions target cold-last-mile loss and spoilage reduction, pharma supply chain resilience and transparency, and cold-storage and port infrastructure investment. It functions as a deal and partnership venue rather than a standards or regulatory forum.
Fortune 500 supply chain executives, shippers and logistics service providers sit alongside cold-storage operators, pharma and life-sciences supply chain leaders, and food retailers, plus a heavy layer of startups and venture investors. Seniority skews senior, with VPs, heads of supply chain and founders. Company types span carriers, 3PLs, cold-storage operators, technology vendors and CPG and pharma shippers.
Pricing & exhibiting
From the organiser · Verified 14 Jul 2026Graduated price-rise schedule (5 tiers) found on Manifest's official partner/media-kit portal (manifestvegas.partners), which lists the same public prices seen on the primary register page. Current 'Early' public tier of $1,995 (matching manife.st/register/ current price) runs until Sept 18, 2026, then rises to $2,195 public until Nov 20, 2026, then $2,395 until Jan 22, 2027, then $2,695 until Feb 7, 2027, then $2,895 on-site (Feb 8-10, 2027) — matching the 'regular' struck-through price on manife.st/register/. Saving vs next tier: $200.
Similar events
Who's going
Be the first to raise your hand.